EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Lilrb4a Suppression Reprograms Microglia to Mitigate APOE4‐Associated Amyloid Plaques and Cerebral Amyloid Angiopathy in Association With a PPAR‐Linked Pro‐Clearance State

Changxu Nie, Ruixi Yang, Xiaotong Wang, Ping Jia, Xueqi Zhang, Yaqi Dai, Xue Bai, Sijia Duan, Yufeng Li, Peng Zheng, Xin Tian iD, Li Jiang iD and 1 more

Advanced Science · 2026

DOI: 10.1002/advs.202524167 ↗

At a glance

Journal article in Advanced Science, 2026. Written by Changxu Nie and 12 co-authors. Institution: Department of Psychiatry, The First Affiliated Hospital of Chongqing Medical University, Department of Neurobiology, School of Basic Medical Sciences…. Major MEDLINE topics: Microglia, Plaque, Amyloid, Cerebral Amyloid Angiopathy, Receptors, Immunologic. 39 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Science Fund for Excellent Young Scholars, Scientific and Technological Research Program of Chongqing Municipal Education Commission, NIDA NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The mouse gene Lilrb4a , an ortholog of human leukocyte immunoglobulin‐like receptor B4 ( LILRB4 ), is markedly upregulated in microglia in Alzheimer's disease models and has been implicated in Apolipoprotein E (APOE)‐related signaling. However, its contribution to amyloid pathology under an APOE4 background remains unclear. Here, 5xFAD mice carrying human APOE4 were used to assess the impact of Lilrb4a reduction by genetic deletion or antisense oligonucleotide treatment. Both approaches significantly reduced cortical amyloid plaque burden and APOE4‐associated cerebral amyloid angiopathy without altering amyloid‐β (Aβ) production. Bulk RNA sequencing identified enrichment of peroxisome proliferator‐activated receptor (PPAR)‐related and broader metabolic pathways in Lilrb4a ‐deficient mice. Consistently, biochemical analyses showed reduced p‐SHP‐2, NF‐κB‐p65, and p‐STAT1, increased p‐STAT3, and induction of anti‐inflammatory and clearance‐associated effectors, including Arg‐1, TGF‐β, and Cyp2e1. In primary microglia, pharmacological interrogation supported a functional contribution of PPAR‐γ signaling to the enhanced Aβ uptake and degradation associated with Lilrb4a suppression, whereas PPAR‐γ agonism recapitulated key pro‐clearance phenotypes in vitro and attenuated amyloid pathology in vivo. Together, these data support Lilrb4a as an APOE4‐associated microglial checkpoint candidate linked to impaired amyloid clearance and identify a PPAR‐linked pro‐clearance program as a potential downstream component of this response.

Subjects

MeSH terms (MEDLINE)

MicrogliaPlaque, AmyloidCerebral Amyloid AngiopathyReceptors, ImmunologicApolipoprotein E4Alzheimer DiseasePeroxisome Proliferator-Activated ReceptorsAnimalsMiceHumansDisease Models, AnimalMice, TransgenicAmyloid beta-PeptidesSignal Transduction

Author keywords

APOE4LILRB4Lilrb4aPPAR‑γamyloid plaquecerebral amyloid angiopathymicroglia

Substances

Receptors, ImmunologicApolipoprotein E4Peroxisome Proliferator-Activated ReceptorsAmyloid beta-Peptides

Authors and institutions

  • Department of Psychiatry, The First Affiliated Hospital of Chongqing Medical University, Department of Neurobiology, School of Basic Medical Sciences, Key Laboratory of Major Brain Disease and Aging Research (Ministry o…
  • Guangzhou National Laboratory, Graduate School of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Jinfeng Laboratory, Chongqing, China.
  • Department of Geriatrics, Laboratory of Research and Translation for Geriatric Diseases, Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Chongqing…
  • Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), Chongqing Medical University, Chongqing, China.

ORCID profiles: Xin Tian, Li Jiang, Chao Wang

Funding

  • National Science Fund for Excellent Young Scholars
  • Scientific and Technological Research Program of Chongqing Municipal Education Commission
  • NIDA NIH HHS
  • Natural Science Foundation of Chongqing Municipal Bureau of Science and Technology
  • Lingang Laboratory AD Special Project
  • National Natural Science Foundation of China
  • Key Technologies Research and Development Program
  • National Outstanding Youth Science Fund Project of National Natural Science Foundation of China

Cite

APA

Nie, C., Yang, R., Wang, X., Jia, P., Zhang, X., Dai, Y., Bai, X., Duan, S., Li, Y., Zheng, P., Tian, X., Jiang, L., & Wang, C. (2026). Lilrb4a Suppression Reprograms Microglia to Mitigate APOE4‐Associated Amyloid Plaques and Cerebral Amyloid Angiopathy in Association With a PPAR‐Linked Pro‐Clearance State. Advanced Science. https://doi.org/10.1002/advs.202524167

Vancouver

Nie C, Yang R, Wang X, Jia P, Zhang X, Dai Y, et al. Lilrb4a Suppression Reprograms Microglia to Mitigate APOE4‐Associated Amyloid Plaques and Cerebral Amyloid Angiopathy in Association With a PPAR‐Linked Pro‐Clearance State. Advanced Science. 2026. doi:10.1002/advs.202524167

BibTeX
@article{Nie2026,
  author = {Nie, Changxu and Yang, Ruixi and Wang, Xiaotong and Jia, Ping and Zhang, Xueqi and Dai, Yaqi and Bai, Xue and Duan, Sijia and Li, Yufeng and Zheng, Peng and Tian, Xin and Jiang, Li and Wang, Chao},
  title = {Lilrb4a Suppression Reprograms Microglia to Mitigate APOE4‐Associated Amyloid Plaques and Cerebral Amyloid Angiopathy in Association With a PPAR‐Linked Pro‐Clearance State},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202524167}
}
Start for free →